rel-1-(1,1-Dimethylethyl) 4-methyl (3R,4S)-3-(4-fluorophenyl)-1,4-piperidinedicarboxylate | 873458-38-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: rel-1-(1,1-Dimethylethyl) 4-methyl (3R,4S)-3-(4-fluorophenyl)-1,4-piperidinedicarboxylate
• 英文别名: 1-O-tert-butyl 4-O-methyl (3R,4S)-3-(4-fluorophenyl)piperidine-1,4-dicarboxylate
• CAS: 873458-38-9
• 化学式: C₁₈H₂₄FNO₄
• 分子量: 337.4
• InChiKey: YXTWLGBODKARPR-GJZGRUSLSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  55.8
• 氢给体数：
  0
• 氢受体数：
  5

文献信息

• Piperidine Compound and Process for Preparing the Same
  申请人：Miyake Tsutomu

  公开号：US20090005355A1

  公开（公告）日：2009-01-01

  The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R 1 is hydrogen atom or a substituent for amino group, R 2 is hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is oxygen atom or —N(R 3 )—, R 3 is hydrogen atom or an optionally substituted alkyl group, R 4a and R 4b may be the same or different, and each is hydrogen atom or an optionally substituted alkyl group, or may be bonded to each other at the both ends to form an alkylene group, or a pharmaceutically acceptable salt thereof, which has an excellent tachykinin receptor antagonistic action.

  本发明提供了一种由式[I]表示的哌啶化合物，其中环A是可选取代的苯环，环B是可选取代的苯环，R1是氢原子或氨基基团的取代基，R2是氢原子、可选取代的羟基、可选取代的氨基、可选取代的烷基、取代的羰基或卤素原子，Z是氧原子或-N（R3）-，R3是氢原子或可选取代的烷基，R4a和R4b可以相同也可以不同，每个是氢原子或可选取代的烷基，或者可以在两端结合形成烷基，或其药学上可接受的盐，具有优异的Tachykinin受体拮抗作用。
• Piperdine Compound and Process for Preparing the Same
  申请人：Miyake Tsutomu

  公开号：US20070244158A1

  公开（公告）日：2007-10-18

  The present invention is to provide a piperidine compound represented by the formula [I]: wherein Ring A is an optionally substituted benzene ring, Ring B is an optionally substituted benzene ring, R 1 is hydrogen atom or a substituent for amino group, R 2 is hydrogen atom, an optionally substituted hydroxyl group, an optionally substituted amino group, an optionally substituted alkyl group, a substituted carbonyl group or a halogen atom, Z is oxygen atom or —N(R 3 )—, R 3 is hydrogen atom or an optionally substituted alkyl group, R 4a and R 4b may be the same or different, and each is hydrogen atom or an optionally substituted alkyl group, or may be bonded to each other at the both ends to form an alkylene group, or a pharmaceutically acceptable salt thereof, which has an excellent tachykinin receptor antagonistic action.

  本发明提供了一种由公式[I]表示的哌啶化合物：其中，环A是可选取代的苯环，环B是可选取代的苯环，R1是氢原子或氨基取代基，R2是氢原子、可选取代的羟基、可选取代的氨基、可选取代的烷基、取代的羰基或卤原子，Z是氧原子或-N(R3)-，R3是氢原子或可选取代的烷基，R4a和R4b可以相同也可以不同，且每个都是氢原子或可选取代的烷基，或者可以在两端结合形成烷基，或其药学上可接受的盐，具有优异的Tachykinin受体拮抗作用。